Catalyst Pharmaceuticals Inc (CPRX)

Inventory turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cost of revenue (ttm)	US$ in thousands	201,267	160,806	136,911	117,031	93,156	87,288	80,919	76,435	71,512	69,159	65,560	64,456	61,273	58,858	57,449	55,725	43,223	34,342	25,531	14,913
Inventory	US$ in thousands	15,644	9,035	10,751	10,328	6,805	7,132	7,850	7,827	7,870	6,950	7,097	4,390	4,651	4,748	1,828	2,211	1,957	600	270	97
Inventory turnover		12.87	17.80	12.73	11.33	13.69	12.24	10.31	9.77	9.09	9.95	9.24	14.68	13.17	12.40	31.43	25.20	22.09	57.24	94.56	153.74

December 31, 2023 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $201,267K ÷ $15,644K
= 12.87

Catalyst Pharmaceuticals Inc's inventory turnover ratio has shown fluctuating trends over the past few years, indicating variations in the efficiency of managing its inventory. The company's inventory turnover ratio ranged from a low of 9.09 to a high of 153.74 over the period provided.

A higher inventory turnover ratio, as seen in some quarters, such as March 31, 2019, indicates that Catalyst Pharmaceuticals Inc is selling and replenishing its inventory quickly, which can be a positive sign of efficiency. Conversely, lower ratios, like those seen in March 31, 2020, and March 31, 2022, suggest the company may be facing challenges in selling its products or managing its inventory levels effectively.

Overall, the company's inventory turnover ratio has shown variability, and it is important for Catalyst Pharmaceuticals Inc to closely monitor this ratio to ensure optimal inventory management and operational efficiency in the future.